Patriot Investment Management Inc. Abb Vie Inc. Transaction History

Patriot Investment Management Inc.

$1.36 Billion
Q3 2024

A detailed history of Patriot Investment Management Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Patriot Investment Management Inc. holds 5,386 shares of ABBV stock, worth $888,636. This represents 0.08% of its overall portfolio holdings.

Number of Shares

5,386

Previous 5,921 9.04%

Holding current value

$888,636

Previous $1.02 Million 4.73%

% of portfolio

0.08%

Previous 0.08%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$163.84 - $199.33 $87,654 - $106,641	-535 Reduced 9.04%	5,386 $1.06 Million
Q2 2024 Jul 15, 2024	BUY	$154.79 - $180.76 $773 - $903	5 Added 0.08%	5,921 $1.02 Million
Q1 2024 Apr 16, 2024	BUY	$159.82 - $182.1 $306,055 - $348,721	1,915 Added 47.86%	5,916 $1.08 Million
Q4 2023 Jan 17, 2024	SELL	$137.6 - $154.97 $72,240 - $81,359	-525 Reduced 11.6%	4,001 $620,000
Q3 2023 Oct 17, 2023	SELL	$133.59 - $154.65 $148,552 - $171,970	-1,112 Reduced 19.72%	4,526 $674,000
Q2 2023 Jul 13, 2023	SELL	$132.51 - $164.9 $5,167 - $6,431	-39 Reduced 0.69%	5,638 $759,000
Q1 2023 Apr 19, 2023	BUY	$144.61 - $166.54 $39,912 - $45,965	276 Added 5.11%	5,677 $904,000
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $7,745 - $9,288	-56 Reduced 1.03%	5,401 $873,000
Q3 2022 Nov 02, 2022	SELL	$134.21 - $153.93 $42,141 - $48,334	-314 Reduced 5.44%	5,457 $732,000
Q2 2022 Jul 26, 2022	SELL	$137.62 - $174.96 $28,624 - $36,391	-208 Reduced 3.48%	5,771 $883,000
Q1 2022 May 02, 2022	BUY	$131.98 - $163.75 $78,660 - $97,595	596 Added 11.07%	5,979 $969,000
Q4 2021 Feb 01, 2022	BUY	$107.43 - $135.93 $60,053 - $75,984	559 Added 11.59%	5,383 $728,000
Q3 2021 Oct 20, 2021	BUY	$106.4 - $120.78 $27,451 - $31,161	258 Added 5.65%	4,824 $520,000
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $28,196 - $31,412	268 Added 6.24%	4,566 $514,000
Q1 2021 Apr 29, 2021	BUY	$102.3 - $112.62 $439,685 - $484,040	4,298 New	4,298 $465,000
Q4 2020 Feb 09, 2021	SELL	$80.49 - $108.67 $297,652 - $401,861	-3,698 Closed	0 $0
Q3 2020 Oct 23, 2020	BUY	$85.91 - $100.83 $5,670 - $6,654	66 Added 1.82%	3,698 $323,000
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $19,663 - $26,312	268 Added 7.97%	3,632 $356,000
Q1 2020 May 06, 2020	SELL	$64.5 - $97.79 $164,346 - $249,168	-2,548 Reduced 43.1%	3,364 $256,000
Q3 2019 Oct 30, 2019	SELL	$62.98 - $75.72 $18,894 - $22,716	-300 Reduced 4.83%	5,912 $440,000
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $19,710 - $25,194	300 Added 5.07%	6,212 $451,000
Q1 2019 May 01, 2019	BUY	$77.14 - $90.79 $456,051 - $536,750	5,912 New	5,912 $476,000

Others Institutions Holding ABBV

# of Institutions

3,841

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $292B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Patriot Investment Management Inc. with notifications on news.

Account

Patriot Investment Management Inc. Abb Vie Inc. Transaction History